SSI Strategy and NDA Group Announce merger, forming a best-in-class Global Life Sciences Consultancy
SSI Strategy and NDA Group are thrilled to announce the merger of our two organizations to form a premier consultancy company, specializing in guiding drug development companies from concept to commercialization.
The merger is an exciting next step, following years of successful collaboration across numerous clients, resulting in the launch of the most innovative therapies available in the world today.
